We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Amgen Inc | NASDAQ:AMGN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 33.02 | 11.86% | 311.41 | 311.40 | 311.95 | 322.54 | 308.68 | 313.42 | 9,644,684 | 00:59:30 |
From May 2019 to May 2024
Medivation Inc. (MDVN) has decided to explore a sale, Reuters reported Monday, citing people familiar with the matter.
The biopharmaceutical company recently rejected a takeover approach from Sanofi SA (SNY, SAN.FR).
According to the Reuters report, Medivation has signed non-disclosure agreements with Pfizer Inc. (PFE) and Amgen Inc. (AMGN).
Medivation shares recently traded up 4.2% to $62.50.
Full story at http://www.reuters.com/article/us-medivation-m-a-exclusive-idUSKCN0Y020U
Write to nymonitoring@dowjones.com
(END) Dow Jones Newswires
May 09, 2016 14:03 ET (18:03 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Amgen Chart |
1 Month Amgen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
